fluoxetine has been researched along with Kidney Failure in 4 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Kidney Failure: A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluoxetine has a nonlinear pharmacokinetic profile." | 2.39 | Clinical pharmacokinetics of fluoxetine. ( Altamura, AC; Moro, AR; Percudani, M, 1994) |
| "We report a case of a potential drug-drug interaction in a woman treated by a first injection of high-dose methotrexate for a T-lymphoblastic lymphoma." | 1.37 | Suspicion of drug-drug interaction between high-dose methotrexate and proton pump inhibitors: a case report - should the practice be changed? ( Bouafia, F; Franchon, E; Gouraud, A; Pham, BN; Ranchon, F; Rioufol, C; Salles, G; Schwiertz, V; Vantard, N; Vial, T; You, B, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Vries-Bouwstra, JK | 1 |
| Allanore, Y | 1 |
| Matucci-Cerinic, M | 1 |
| Balbir-Gurman, A | 1 |
| Ranchon, F | 1 |
| Vantard, N | 1 |
| Gouraud, A | 1 |
| Schwiertz, V | 1 |
| Franchon, E | 1 |
| Pham, BN | 1 |
| Vial, T | 1 |
| You, B | 1 |
| Bouafia, F | 1 |
| Salles, G | 1 |
| Rioufol, C | 1 |
| Labos, C | 1 |
| Dasgupta, K | 1 |
| Nedjar, H | 1 |
| Turecki, G | 1 |
| Rahme, E | 1 |
| Altamura, AC | 1 |
| Moro, AR | 1 |
| Percudani, M | 1 |
1 review available for fluoxetine and Kidney Failure
| Article | Year |
|---|---|
Clinical pharmacokinetics of fluoxetine.
Topics: Administration, Oral; Aged; Aging; Biological Availability; Dose-Response Relationship, Drug; Drug I | 1994 |
3 other studies available for fluoxetine and Kidney Failure
| Article | Year |
|---|---|
Worldwide Expert Agreement on Updated Recommendations for the Treatment of Systemic Sclerosis.
Topics: Adrenal Cortex Hormones; Angiotensin-Converting Enzyme Inhibitors; Europe; Fluoxetine; Gastroesophag | 2020 |
Suspicion of drug-drug interaction between high-dose methotrexate and proton pump inhibitors: a case report - should the practice be changed?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acyclovir; Antimetabolites, Antineoplastic; Antiviral Agent | 2011 |
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.
Topics: Adrenal Cortex Hormones; Age Factors; Aged; Anemia; Angioplasty; Anticoagulants; Antihypertensive Ag | 2011 |